TYRP1

Overview

TYRP1 encodes tyrosinase related protein 1, a melanosomal enzyme that works alongside tyrosinase (TYR) and dopachrome tautomerase (DCT) to complete the synthesis of eumelanin, the brown-black pigment that gives most human skin, hair, and eyes their color. While tyrosinase performs the entry steps of the pathway, TYRP1 acts further downstream, oxidizing the intermediate DHICA into a carboxylated indole-quinone that polymerizes into stable eumelanin. TYRP1 also plays a structural role that goes beyond its own catalytic output: it physically associates with tyrosinase inside the melanosome and helps stabilize it, so a functioning TYRP1 protein supports the activity of the entire pigment-producing enzyme complex, not just its own reaction step.

TYRP1 is a close evolutionary relative of TYR and DCT, sharing the same overall protein architecture, yet it stands out chemically because its active site is built around zinc rather than the copper center used by tyrosinase. This difference was only resolved structurally in the past decade and explains why TYRP1, despite sequence similarity to TYR, catalyzes a distinct oxidation reaction rather than duplicating the tyrosine hydroxylase and DOPA oxidase steps performed by its paralog.

Clinically, TYRP1 is best known as the gene underlying oculocutaneous albinism type 3, a form of albinism first and most extensively characterized in southern African populations, producing a reddish-brown rather than a fully depigmented phenotype. Common, non-pathogenic TYRP1 variants also shape ordinary hair color variation, and the gene is retained as an active lineage marker in many melanomas, connecting this single gene to inherited pigmentation disorders, forensic pigmentation prediction, and melanocytic cancer pathology.

Deep Dive

Catalytic Role and the Zinc Active Site

For many years TYRP1 was assumed to share a copper-based catalytic mechanism with tyrosinase, given the strong sequence homology between the two proteins. Structural studies resolving the crystal structure of human TYRP1 showed instead that its active site coordinates a pair of zinc ions rather than copper, a finding that reframed how the enzyme family is understood. This binuclear zinc center supports the specific chemistry TYRP1 performs, oxidizing 5,6-dihydroxyindole-2-carboxylic acid (DHICA) into an indole-5,6-quinone-2-carboxylic acid intermediate, one of the final steps before this branch of the pathway polymerizes into mature eumelanin.

Stabilization of the Melanosomal Enzyme Complex

TYRP1 is not simply a sequential enzyme sitting downstream of TYR and DCT in a linear pathway. Biochemical studies show that TYRP1, TYR, and DCT physically associate within the melanosomal membrane, and TYRP1 in particular appears to help stabilize tyrosinase and retain it within maturing melanosomes. This means a cell with reduced TYRP1 function can show diminished tyrosinase-driven pigment output even when the TYR gene itself carries no pathogenic mutation, a mechanism that helps explain why TYRP1 loss produces a distinctive but still substantially pigmented phenotype rather than a complete absence of melanin.

Genotype-Phenotype Correlation in OCA3

Biallelic loss-of-function TYRP1 mutations cause oculocutaneous albinism type 3, historically termed rufous or brown albinism, which was first characterized in detail in southern African Black populations carrying specific founder mutations. Unlike OCA1, where tyrosinase loss can abolish melanin production almost entirely, TYRP1 loss still permits substantial DHI-based pigment synthesis through the non-enzymatic and DCT-dependent branches of the pathway, producing a reddish-brown hair color, copper-toned skin, and light irides rather than the profound depigmentation of OCA1A. This genotype-phenotype relationship illustrates how the specific enzymatic step disrupted within a shared pathway determines the character, not just the severity, of resulting albinism.

TYRP1 in Forensic and Population Pigmentation Genetics

Beyond its role in rare albinism, common regulatory and coding TYRP1 variants contribute measurably to the ordinary range of human hair color, most clearly along the brown-to-black spectrum. These variants have been incorporated into forensic DNA phenotyping panels such as HIrisPlex, which combine markers across TYR, TYRP1, MC1R, and other pigmentation genes to predict hair and eye color from a genetic sample. This population-level variation is mechanistically distinct from the rare, severe coding mutations that cause OCA3, illustrating how the same gene can harbor both common variation shaping normal appearance and rare variation causing overt disease.

TYRP1 as a Melanocytic Lineage Marker in Melanoma

Because TYRP1 expression is largely restricted to differentiated melanocytes and retained in most melanomas, the protein, historically referred to as gp75 in the tumor immunology literature, is used diagnostically as an immunohistochemical marker of melanocytic lineage alongside markers such as Melan-A/MART-1 and HMB-45. TYRP1 expression is controlled by the same MITF-driven transcriptional program implicated in melanoma proliferation and differentiation states, so TYRP1 activity indirectly tracks where a given melanoma sits along that differentiation axis, information that has informed research into TYRP1-directed immunotherapy approaches in addition to its diagnostic use.

Biomarker and Testing Interpretation

Clinical TYRP1 sequencing is typically performed as part of a combined oculocutaneous albinism gene panel alongside TYR, OCA2, and SLC45A2, since these conditions overlap substantially in early presentation but diverge in eventual phenotype and inheritance counseling implications. TYRP1 immunohistochemistry in tumor pathology should be interpreted alongside other melanocytic markers rather than in isolation, since TYRP1 expression can vary with tumor differentiation state and is not itself a marker of malignancy.